Navid Ezra
Physician · California Dermatology Institute PC
Credentials: · · · ·
History
- 2023–Present
California Dermatology Institute PC
- 2015–2017
Rheumatology
- 2010–2011
Preliminary or Transitional Year
2006–2010
Research
High-density lipoprotein: antioxidant and anti-inflammatory properties
Review · Current Atherosclerosis Reports · 2007 · 69 citations
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome
Blood · 2024 · 53 citations
Human immunodeficiency virus and leishmaniasis
Journal of Global Infectious Diseases · 2010 · First of 3 authors · 50 citations
- NM
5 papers
- DB
4 papers

3 papers
- AA
2 papers · 1 as a fellow
- AA
2 papers · 2 as a resident
- JH
2 papers

2 papers · 1 as a resident
- SB
2 papers
Clinical trials
- 2026–2031
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
- 2026–2027
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Site PI · Recruiting · Phase 2
Eli Lilly and Company
- 2026–2027
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Site PI · Recruiting · Phase 2
Eli Lilly and Company
- 2026–2030
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals

